Skip to content

Douglas A. Corley, MD, PhD

douglas.corley@kp.org

Kaiser Permanente Researcher Profiles

Douglas  Corley, MD, PhD

Douglas A. Corley, MD, PhD, is The Permanente Medical Group’s Chief Research Officer and has been a research scientist at the Kaiser Permanente Northern California Division of Research since 2002. He is also a board-certified gastroenterologist who practices at the Kaiser Permanente, San Francisco Medical Center.

Dr. Corley has expertise in building collaborative, transdisciplinary diverse teams; developing large clinical and translational research programs; and educational development. Through multi-center, team-based collaborations and a series of over 46 funded awards, including more than 22 NIH, NCI and other federal grants/contracts, his research includes fundamental risk factor epidemiology in emerging diseases; broad-based disease pathway discovery in genetic and metabolic epidemiology; complex pharmacoepidemiology, including US Food and Drug Administration collaborations that modified drug safety labeling; identification and reduction of demographic disparities in medical care outcomes; randomized trials and multi-level investigations into clinical care pathways. These have resulted in multiple first and senior author publications in the New England Journal of Medicine, JAMA, Annals of Internal Medicine and leading epidemiology and specialty journals. He has been the co-Editor-in-Chief of a leading specialty journal (Gastroenterology) and co-led efforts to modify journalistic practices to increase equity in publications.

In addition to federal grants, he co-led securing funding and infrastructure development at Kaiser Permanente for a novel regional physician researcher program, integration of the Delivery Science and Applied Research program (DARE), and development of an enterprise-level Learning Health Initiative to accelerate high-volume practice change, improve value, and increase care value.  Funded by The Permanente Medical Group, these efforts identify modifiable challenges likely to influence patient and system outcomes, develop collaborations between clinicians and traditional full-time scientists/epidemiologists, uses extremely large data sources for relevant research, and develop mechanisms for rapid implementation (and re-evaluation) of research findings and intervention outcomes.

After completing medical school at the University of Pennsylvania, Dr. Corley completed an internal medicine residency at the Brigham & Women’s Hospital of the Harvard Medical School in Boston, Massachusetts; and a gastroenterology fellowship at the University of California, San Francisco (UCSF). Dr. Corley subsequently obtained a master’s degree in public health and a doctorate in epidemiology at the University of California, Berkeley, School of Public Health. Prior to joining the Division of Research, he was on the full-time gastroenterology faculty at UCSF, where he was the chief of the UCSF GI Faculty Practice; he is currently a UCSF Professor of Clinical Medicine (non-salaried).

Current Positions

  • Chief Research Officer, The Permanente Medical Group
  • Research Scientist III, Division of Research, Kaiser Permanente Northern California
  • Attending Gastroenterologist, Kaiser Permanente, San Francisco Medical Center
  • Associate Member, University of California, San Francisco Comprehensive Cancer Center
  • Clinical Professor of Medicine, University of California, San Francisco

Section Affiliations

Studies

Addressing Disparities in Outcomes of Screening for Colorectal Cancer in Community-Based Settings

This study will evaluate the colorectal cancer screening continuum — tests, screening quality, follow-up care, and health outcomes — over a 20-year time period that covers before, during, and after implementation of an organized colorectal cancer screening at KPNC and KPSC. We will examine receipt and quality of screening by race and ethnicity as well as trends in colorectal cancer screening outcomes by race and ethnicity. We will also use microsimulation modeling to estimate the relative contribution of screening process care gaps on racial and ethnic disparities in colorectal cancer incidence and mortality in various populations.

Investigator: Corley, Douglas

Funder: National Cancer Institute

NRG Oncology NCORP Research Base – NRG-CC005 FORTE (supplement)

In the initial phase of this study, we will manually review patients for eligibility for initial contact; complete a patient identification and tracking database; and develop and submit supplemental electronic IRB/email consent documents.

Investigator: Corley, Douglas

Funder: National Cancer Institute

NRG Oncology NCORP Research Base

This is a non-inferiority trial design comparing colorectal cancer incidence in trial participants with 1-2 non-advanced adenomas randomized to recommendation for a 5- and 10-year surveillance colonoscopy exam vs. a 10-year surveillance colonoscopy exam.

Investigator: Corley, Douglas

Funder: National Cancer Institute

System-Level Capture of Family History Data to Assess Risk of Cancer and Provide Longitudinal Care Coordination

Genetic risk and family history, which includes personal medical history, increasingly influence medical care, but optimal methods for capturing the hereditary risk of disease and the outcomes of such assessments are unknown. Using inherited cancer as a model, this study will: 1) Test scalable interventions for integrating family and genetic risk data into the care of large populations; 2) Evaluate significant patient-centered and medical-outcomes resulting from systems-level family history assessment; and 3) Determine the resources needed for such interventions.

Investigator: Corley, Douglas

Funder: Patient-Centered Outcomes Research Institute

Validation and Extension of the Michigan Barrett’s Esophagus pREdiction Tool (M-BERET)

This project will validate whether a clinical tool can predict the presence of Barrett’s esophagus and the development of esophageal adenocarcinoma.

Investigator: Corley, Douglas

Funder: U.S. Department of Veterans Affairs

Gene Dependent Cancer Risk and Optimal Cancer Prevention Strategies in Lynch Syndrome

As part of a “K” training award from the National Institutes of Health, and within the overall colorectal cancer research program at Kaiser Permanente Northern California, this project will support additional analyses regarding the identification of persons at high hereditary risk for colorectal cancer (e.g., Lynch syndrome) and their use of preventive and treatment modalities.

Investigator: Corley, Douglas

Funder: National Cancer Institute

Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)

This study is part of the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) program, which aims to enhance understanding of the implementation and effects of screening as practiced in multiple, heterogeneous health care environments in the United States. Within this program, proposed research projects must cover long-term observations of diverse cohorts of patients who are eligible for screening. In addition to observational research to evaluate factors that affect the quality of the screening process, projects must also develop and pilot-test interventions aimed at improving the screening process. This study of colorectal cancer screening precision and outcomes will build upon work completed and in progress from the first five years of PROSPR.

Investigator: Corley, Douglas

Funder: National Cancer Institute

Effectiveness of Screening for Colorectal Cancer in Average Risk Adults: Colonoscopy vs. Fecal Immunochemical Test (FIT)

This project will evaluate the effectiveness of screening fecal immunochemical testing (FIT) versus screening colonoscopy in reducing the risk of death from colorectal cancer in average risk men and women who receive their care in community settings. We will also develop new statistical methods to account for levels of adherence to recommended screening intervals when comparing tests.

Investigator: Corley, Douglas

Funder: National Cancer Institute

Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening

The aims of this study are: 1) To build a comprehensive risk-prediction model for colorectal cancer and advanced adenoma in 45,000 colorectal tumors and 45,000 controls based on existing common and rare genome-wide genetic variants, demographic characteristics, and lifestyle and environmental risk factors. 2) To evaluate the risk-prediction models by calibrating and validating the models in the community-based RPGEH cohort and compare it with current screening guidelines and published risk prediction models. 3) To translate abstract risk prediction estimates into individually tailored recommendations that can be used in public health and clinical settings. We will use our developed absolute risk estimates to recommend age to start intervention and the type of screening modality. We will also incorporate a cost-benefit in the decision curve analysis to help clinical decision making.

Investigator: Corley, Douglas

Funder: National Cancer Institute

Kaiser Permanente PROSPR Cervical Cancer Prevention and Screening (CCaPS) Center

The purpose of this project is to expand PROSPR’s activities related to screening women for cervical cancer. PROSPR is the National Cancer Institute’s Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. This specific application will extend an existing collaboration between Kaiser Permanente’s Northern and Southern California regions to include data collection and analyses on cervical cancer with co-principal investigators Michael Silverberg (KPNC) and Chun Chao (KPSC).

Investigator: Corley, Douglas

Funder: National Cancer Institute

Retrospective Validation of MeScore for Identification of Colorectal Cancer

The purpose of this study is to assess the efficacy of the computational method MeScore CRC in risk stratification for colorectal cancer in a seemingly healthy population (average risk).

Investigator: Corley, Douglas

Funder: Medial Research

Effectiveness of Screening Colonoscopy in Reducing Deaths from Colorectal Cancer (SCOLAR)

A case-control study to evaluate the associations between commonly performed tests (e.g. colonoscopy) and mortality from colon cancer.

Investigator: Corley, Douglas

Funder: National Cancer Institute

Optimizing Colonoscopy and Fecal Immunochemical Tests for Community-Based Screening, COLOFIT(S)

An evaluation of the entire colorectal cancer screening process to optimize end results. The study includes evaluation of screen-failures (persons who had cancer detected outside of screening), failures of colonoscopy detection (and causes), and differences between screen detected and non-screen detected cancers.

Investigator: Corley, Douglas

Funder: National Cancer Institute

A New Lab-Based Algorithm for HCC Surveillance in Patients with Cirrhosis

The objective of this study is to optimize and test the predictive value of a model in predicting the occurrence of HCC and the performance characteristics of cancer screening tests among patients with cirrhosis and hepatitis C infection.

Investigator: Corley, Douglas

Funder: National Cancer Institute

Long-Term, Prospective, Observational Study of the Risk of Cancer Among Pantoprazole (Protonix) Users

The objective of this study is to determine if there is an increased risk of cancer with pantoprazole (Protonix®), relative to other proton pump inhibitors.

Investigator: Corley, Douglas

Funder: Wyeth-Lederle S.p.A.

Publications

Impact of a scalable training program on the quality of colonoscopy performance and risk of post-colonoscopy colorectal cancer

Authors: Corley, Douglas A;Jensen, Christopher D;Lee, Jeffrey K;Contreras, Richard;Fireman, Bruce H;Quesenberry, Charles P;et al.

Gastrointest Endosc. 2023 Oct;98(4):609-617. Epub 2023-04-23.

PubMed abstract

Evaluating Different Approaches for Calculating Adenoma Detection Rate: Is Screening Colonoscopy the Gold Standard?

Authors: Corley, Douglas A;Jensen, Christopher D;Chubak, Jessica;Schottinger, Joanne E;Halm, Ethan A;Udaltsova, Natalia;Prospr Precise Consortium,

Gastroenterology. 2023 Sep;165(3):784-787.e4. Epub 2023-05-30.

PubMed abstract

Risk of colorectal cancer and colorectal cancer mortality beginning one year after a negative fecal occult blood test, among screen-eligible 76-85-year-olds

Authors: Dalmat, Ronit R;Burnett-Hartman, Andrea N;Halm, Ethan A;Chubak, Jessica;et al.

Cancer Epidemiol Biomarkers Prev. 2023 Jul 14.

PubMed abstract

The implementation checklist: A pragmatic instrument for accelerating research-to-implementation cycles

Authors: Prausnitz, Stephanie;Altschuler, Andrea;Herrinton, Lisa J;Avins, Andrew L;Corley, Douglas A

Learn Health Syst. 2023 Jul;7(3):e10359. Epub 2023-01-27.

PubMed abstract

Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States

Authors: Li, Dan;Jiang, Sheng-Fang;Lei, Nan Ye;Shah, Shailja C;Corley, Douglas A

Gastroenterology. 2023 May 02.

PubMed abstract

Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review

Authors: Selby, Kevin; Corley, Douglas A; et al.

J Natl Cancer Inst. 2023 Apr 11;115(4):375-384.

PubMed abstract

Provider- and Facility-Level Variation in Pre-Cancerous Cervical Biopsy Diagnoses

Authors: Del Vecchio, Natalie J; Corley, Douglas A; Silverberg, Michael; et al.

J Low Genit Tract Dis. 2023 Apr 01;27(2):113-119. Epub 2023-01-17.

PubMed abstract

Overall and Annual Post-Colonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-sectional Study

Authors: Lee, Jeffrey K; H-E Kang, James; Merchant, Sophie A; Jensen, Christopher D; Burr, Nicholas E; Corley, Douglas A

Clin Gastroenterol Hepatol. 2023 Mar 23.

PubMed abstract

Risk-stratified screening for colorectal cancer using genetic and environmental risk factors: A cost-effectiveness analysis based on real-world data

Authors: van den Puttelaar, Rosita; Lee, Jeffrey K; Sakoda, Lori C; Corley, Douglas A; Lansdorp-Vogelaar, Iris; et al.

Clin Gastroenterol Hepatol. 2023 Mar 09.

PubMed abstract

Validation of a genetic-enhanced risk prediction model for colorectal cancer in a large community-based cohort

Authors: Su, Yu-Ru; Sakoda, Lori C; Lee, Jeffrey K; Corley, Douglas A; Hsu, Li; et al.

Cancer Epidemiol Biomarkers Prev. 2023 Mar 06;32(3):353-362.

PubMed abstract

Post-Colonoscopy Colorectal Cancer Etiologies in a Large Integrated US Health Care Setting

Authors: Leung, Lawrence Jun; Lee, Jeffrey K; Merchant, Sophie A; Jensen, Christopher D; Alam, Asim; Corley, Douglas A

Gastroenterology. 2023 Mar;164(3):470-472.e3. Epub 2022-12-01.

PubMed abstract

Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings

Authors: Chao, Chun R; Silverberg, Michael J; Corley, Douglas A; Wheeler, Cosette M; et al.

Cancer Med. 2023 Feb;12(3):3705-3717. Epub 2022-09-15.

PubMed abstract

Biopsy of Non-tumor Sites After Biopsy of a Colorectal Cancer is not Associated With Metachronous Cancers: A Case-control Study

Authors: Lam, Angela Y; Lee, Jeffrey K; Merchant, Sophie; Jensen, Christopher D; Sedki, Mai; Corley, Douglas A

Clin Gastroenterol Hepatol. 2023 Feb;21(2):487-496.e3. Epub 2022-05-26.

PubMed abstract

Combining Asian-European Genome-Wide Association Studies of Colorectal Cancer Improves Risk Prediction Across Race and Ethnicity

Authors: Thomas, Minta; Sakoda, Lori C; Lee, Jeffrey K; Corley, Douglas A; Hsu, Li; et al.

medRxiv. 2023 Jan 19.

PubMed abstract

Risk of colorectal cancer and colorectal cancer mortality beginning ten years after a negative colonoscopy, among screen-eligible adults 76-85 years old

Authors: Dalmat, Ronit R; Corley, Douglas A; Levin, Theodore R; Chubak, Jessica; et al.

Cancer Epidemiol Biomarkers Prev. 2023 Jan 09;32(1):37-45.

PubMed abstract

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

Authors: Fernandez-Rozadilla, Ceres; Corley, Douglas; Sakoda, Lori; Peters, Ulrike; et al.

Nat Genet. 2023 Jan;55(1):89-99. Epub 2022-12-20.

PubMed abstract

Informative presence in electronic health record data: a challenge in implementing study exclusion criteria

Authors: Chubak, Jessica; Dalmat, Ronit R; Weiss, Noel S; Doria-Rose, V Paul; Corley, Douglas A; Kamineni, Aruna

Epidemiology. 2023 Jan 01;34(1):29-32. Epub 2022-09-20.

PubMed abstract

Limitations to Health Care Quality Measurement: Assessing Hospital Variation in Risk of Cardiac Events After Noncardiac Surgery

Authors: Yap, Edward N; Dusendang, Jennifer R; Ng, Kevin P; Keny, Hemant V; Solomon, Matthew D; Cohn, Bradley R; Corley, Douglas A; Herrinton, Lisa J

Popul Health Manag. 2022 Dec;25(6):712-720. Epub 2022-09-12.

PubMed abstract

Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines

Authors: Kamineni, Aruna; Corley, Douglas A; Burnett-Hartman, Andrea N; et al.

Ann Intern Med. 2022 Nov;175(11):1582-1590. Epub 2022-09-27.

PubMed abstract

Physician Adenoma Detection Rates and Colorectal Cancer-Reply

Authors: Corley, Douglas A; Schottinger, Joanne; Jensen, Christopher

JAMA. 2022 10 11;328(14):1462-1463.

PubMed abstract

Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies

Authors: Cavazos, Taylor B; Alexeeff, Stacey; Van Den Eeden, Stephen; Corley, Douglas A; Kushi, Lawrence H; Habel, Laurel A; Sakoda, Lori C; Witte, John S; et al.

BMC Med. 2022 10 06;20(1):332. Epub 2022-10-06.

PubMed abstract

Developing Meaningful Health Care Quality Metrics: An Example From Colonoscopy and Adenoma Detection

Authors: Corley, Douglas

Ann Intern Med. 2022 10;175(10):1479-1480. Epub 2022-09-27.

PubMed abstract

eQTL set-based association analysis identifies novel susceptibility loci for Barrett’s esophagus and esophageal adenocarcinoma

Authors: Wang, Xiaoyu; Risch, Harvey A; Dai, James Y; et al.

Cancer Epidemiol Biomarkers Prev. 2022 Sep 02;31(9):1735-1745.

PubMed abstract

Age-stratified prevalence and predictors of neoplasia among US adults undergoing screening colonoscopy in a national endoscopy registry

Authors: Liang, Peter S; Williams, J Lucas; Dominitz, Jason A; Corley, Douglas A; Zauber, Ann G

Gastroenterology. 2022 09;163(3):742-753.e4. Epub 2022-05-26.

PubMed abstract

Impact of the COVID-19 pandemic on fecal immunochemical testing, colonoscopy services, and colorectal neoplasia detection in a large United States community-based population

Authors: Lee, Jeffrey K; Li, Dan; Corley, Douglas A; Levin, Theodore R; et al.

Gastroenterology. 2022 09;163(3):723-731.e6. Epub 2022-05-14.

PubMed abstract

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda

Authors: Beaber, Elisabeth F; Corley, Douglas A; Doria-Rose, V Paul; et al.

Cancer Epidemiol Biomarkers Prev. 2022 Aug 02;31(8):1521-1531.

PubMed abstract

Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval

Authors: Chubak, Jessica; Burnett-Hartman, Andrea N; Barlow, William E; Corley, Douglas A; Croswell, Jennifer M; Neslund-Dudas, Christine; Vachani, Anil; Silver, Michelle I; Tiro, Jasmin A; Kamineni, Aruna

Cancer Epidemiol Biomarkers Prev. 2022 Aug 02;31(8):1517-1520.

PubMed abstract

Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study

Authors: Skarbinski, Jacek; Wood, Mariah S; Chervo, Tyler C; Schapiro, Jeffrey M; Elkin, Eric P; Valice, Emily; Amsden, Laura B; Hsiao, Crystal; Quesenberry, Charles; Corley, Douglas A; Kushi, Lawrence H

Lancet Reg Health Am. 2022 Jun 16:100297.

PubMed abstract

Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer

Authors: Schottinger, Joanne E; Lee, Jeffrey K; Fireman, Bruce H; Quesenberry, Charles P; Corley, Douglas A; et al.

JAMA. 2022 06 07;327(21):2114-2122.

PubMed abstract

Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies

Authors: Figueiredo, Jane C; Kushi, Lawrence H; Corley, Douglas A; Skarbinski, Jacek; et al.

Open Forum Infect Dis. 2022 Jun;9(6):ofac171. Epub 2022-04-27.

PubMed abstract

Declining Colectomy Rates for Nonmalignant Colorectal Polyps in a Large, Ethnically Diverse, Community-based Population

Authors: Alam, Asim; Corley, Douglas A; Lee, Jeffrey K; Lee, Jeffrey K; et al.

Clin Transl Gastroenterol. 2022 05 01;13(5):e00477. Epub 2022-05-01.

PubMed abstract

Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study

Authors: Archambault, Alexi N; Sakoda, Lori C; Lee, Jeffrey K; Corley, Douglas A; Hayes, Richard B; et al.

J Natl Cancer Inst. 2022 04 11;114(4):528-539.

PubMed abstract

Association between Improved Colorectal Screening and Racial Disparities

Authors: Doubeni, Chyke A; Corley, Douglas A; Zhao, Wei; Lau, YanKwan; Jensen, Christopher D; Levin, Theodore R

N Engl J Med. 2022 02 24;386(8):796-798.

PubMed abstract

POST-ENDOSCOPY ESOPHAGEAL NEOPLASIA IN BARRETT’S ESOPHAGUS: CONSENSUS STATEMENTS FROM AN INTERNATIONAL EXPERT PANEL

Authors: Wani, Sachin; Yadlapati, Rena; Singh, Siddharth; Sawas, Tarek; Katzka, David A; Post-Endoscopy Esophageal Neoplasia Expert Consensus Panel,

Gastroenterology. 2022 02;162(2):366-372. Epub 2021-10-14.

PubMed abstract

The association of bowel function, participation in life activities, and quality of life in rectal cancer survivors

Authors: Bulkley, Joanna E; McMullen, Carmit K; Rawlings, Andreea M; Krouse, Robert S; Francisco, Melanie C; Sterrett, Andrew T; Burnett-Hartman, Andrea N; Pawloski, Pamala A; Corley, Douglas A; Colwell, Janice C; Feigelson, Heather Spencer

Qual Life Res. 2022 Feb;31(2):487-495. Epub 2021-07-12.

PubMed abstract

Advancing Diversity, Equity, and Inclusion in Scientific Publishing

Authors: Doubeni, Chyke A; Corley, Douglas A; Peek, Richard M

Gastroenterology. 2022 01;162(1):59-62.e1. Epub 2021-11-03.

PubMed abstract

Rising Early-Onset Colorectal Cancer Incidence is Not an Artifact of Increased Screening Colonoscopy Use in a Large, Diverse Healthcare System

Authors: Lee, Jeffrey K; Merchant, Sophie A; Jensen, Christopher D; Murphy, Caitlin C; Udaltsova, Natalia; Corley, Douglas A

Gastroenterology. 2022 01;162(1):325-327.e3. Epub 2021-09-20.

PubMed abstract

Program components and results from an organized colorectal cancer screening program using annual fecal immunochemical testing

Authors: Selby, Kevin; Jensen, Christopher D; Levin, Theodore R; Lee, Jeffrey K; Schottinger, Joanne E; Zhao, Wei K; Corley, Douglas A; Doubeni, Chyke A

Clin Gastroenterol Hepatol. 2022 01;20(1):145-152. Epub 2020-09-30.

PubMed abstract

The learning health system: the tools are here, why aren’t we moving forward? Embedding researchers and delivery science for accelerating health care change

Authors: Corley, Douglas A; Kilbourne, Amy

Gastroenterology. 2021 12;161(6):1747-1750. Epub 2021-08-09.

PubMed abstract

Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond

Authors: Croswell, Jennifer M; Corley, Douglas A; Lafata, Jennifer Elston; Haas, Jennifer S; Inadomi, John M; Kamineni, Aruna; Ritzwoller, Debra P; Vachani, Anil; Zheng, Yingye; National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) II Consortium,

Prev Med. 2021 10;151:106595. Epub 2021-06-30.

PubMed abstract

Risk stratification for colorectal cancer in individuals with subtypes of serrated polyps

Authors: Li, Dan; Doherty, Amanda R; Raju, Menaka; Liu, Liyan; Lei, Nan Ye; Amsden, Laura B; Lee, Jeffrey K; Levin, Theodore R; Corley, Douglas A; Herrinton, Lisa J

Gut. 2021 Aug 11.

PubMed abstract

Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-based Cohort of Patients With Cirrhosis of Multiple Etiologies

Authors: Tayob, Nabihah; Corley, Douglas A; Christie, Israel; Almers, Lucy; Rahal, Ahmed K; Richardson, Peter; White, Donna L; Davila, Jessica; Kanwal, Fasiha; El-Serag, Hashem B

Clin Gastroenterol Hepatol. 2021 07;19(7):1443-1450.e6. Epub 2020-08-05.

PubMed abstract

Editors in Chief, Gastroenterology

Authors: Stange, Eduard F; von Bünau, Rudolf; Erhardt, Andreas

Gastroenterology. 2021 06;160(7):2632. Epub 2020-12-30.

PubMed abstract

The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer

Authors: Doubeni CA; Corley DA; Lee JK; Levin TR; Weiss NS; et al.

J Med Screen. 2021 06;28(2):140-147. Epub 2020-05-21.

PubMed abstract

COVID-19: Guidance for What Clinicians and Scientists Should Do and When

Authors: Corley, Douglas A; Peek, Richard M

Gastroenterology. 2021 05;160(6):1922-1923.

PubMed abstract

Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction

Authors: Rubenstein, Joel H; Raghunathan, Trivellore; Doan, Cecilia; Schneider, Jennifer; Zhao, Wei; Metko, Valbona; Nofz, Kimberly; Khodadost, Maryam; Corley, Douglas A

Am J Gastroenterol. 2021 05 01;116(5):949-957.

PubMed abstract

Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma

Authors: Dighe, Shruti G; Corley, Douglas A; Buas, Matthew F; et al.

Carcinogenesis. 2021 04 17;42(3):369-377.

PubMed abstract

Response to Li and Hopper

Authors: Thomas, Minta; Sakoda, Lori C; Lee, Jeffrey K; Corley, Douglas A; Hsu, Li; et al.

Am J Hum Genet. 2021 03 04;108(3):527-529.

PubMed abstract

Paradigm-Shifting Research in Gastroenterology, Hepatology, and Nutrition: A Top 20 List of Articles Published in 2020

Authors: Corley, Douglas A; Peek, Richard M; Simpson, Brook A

Gastroenterology. 2021 03;160(4):979-981. Epub 2021-01-14.

PubMed abstract

Cancer Screening during COVID-19: A Perspective from NCI’s PROSPR consortium

Authors: National Cancer Institute’s PROSPR Consortium,; Corley, Douglas A; Haas, Jennifer S; et al.

Gastroenterology. 2021 03;160(4):999-1002. Epub 2020-10-21.

PubMed abstract

Natural language processing for the accurate identification of colorectal cancer mismatch repair status in Lynch syndrome screening

Authors: Li D; Udaltsova N; Layefsky E; Doan C; Corley DA

Clin Gastroenterol Hepatol. 2021 03;19(3):610-612.e1. Epub 2020-02-07.

PubMed abstract

Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts

Authors: Graff, Rebecca E; Alexeeff, Stacey E; Corley, Douglas A; Kushi, Lawrence H; Van Den Eeden, Stephen K; Habel, Laurel A; Sakoda, Lori C; et al.

Nat Commun. 2021 02 12;12(1):970. Epub 2021-02-12.

PubMed abstract

Influence of Telemedicine-First Intervention on Patient Visit Choice, Post-Visit Care, and Patient Satisfaction in Gastroenterology

Authors: Munroe, Craig A; Lin, Teresa Y; Rouillard, Smita; Fox, Jeffrey; Lee, Jeffrey K; Corley, Douglas A

Gastroenterology. 2021 02;160(3):929-931.e2. Epub 2020-10-16.

PubMed abstract

Sex-Specific Genetic Associations for Barrett’s Esophagus and Esophageal Adenocarcinoma

Authors: Dong, Jing; Corley, Douglas A; Thrift, Aaron P; et al.

Gastroenterology. 2020 12;159(6):2065-2076.e1. Epub 2020-09-09.

PubMed abstract

Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-based Colorectal Cancer Screening Program

Authors: Levin TR; Jensen CD; Chawla NM; Sakoda LC; Lee JK; Zhao WK; Landau MA; Herm A; Eby E; Quesenberry CP; Corley DA

Gastroenterology. 2020 11;159(5):1695-1704.e1. Epub 2020-07-20.

PubMed abstract

Standardized reporting and management of suspicious findings on chest computed tomography is associated with improved lung cancer diagnosis in an observational study

Authors: Urbania TH; Dusendang JR; Herrinton LJ; Alexeeff S; Corley DA; Ely S; Patel A; Osinski T; Sakoda LC

Chest. 2020 11;158(5):2211-2220. Epub 2020-06-17.

PubMed abstract

Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus

Authors: Xie SH; Corley DA; Lagergren J; et al.

Clin Gastroenterol Hepatol. 2020 11;18(12):2701-2709.e3. Epub 2019-11-19.

PubMed abstract

Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts

Authors: Rashkin, Sara R; Alexeeff, Stacey E; Corley, Douglas A; Kushi, Lawrence H; Van Den Eeden, Stephen K; Habel, Laurel A; Sakoda, Lori C; Witte, John S; et al.

Nat Commun. 2020 09 04;11(1):4423. Epub 2020-09-04.

PubMed abstract

Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk

Authors: Thomas, Minta; Sakoda, Lori C; Lee, Jeffrey K; Corley, Douglas A; Hsu, Li; et al.

Am J Hum Genet. 2020 09 03;107(3):432-444. Epub 2020-08-05.

PubMed abstract

Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps

Authors: Li D; Liu L; Fevrier HB; Alexeeff SE; Doherty AR; Raju M; Amsden LB; Lee JK; Levin TR; Corley DA; Herrinton LJ

Gastroenterology. 2020 08;159(2):502-511.e2. Epub 2020-04-08.

PubMed abstract

ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS: AN EXAMPLE FROM COLORECTAL CANCER SCREENING

Authors: Zheng, Yingye; Corley, Douglas A; Doubeni, Chyke; Halm, Ethan; Shortreed, Susan M; Barlow, William E; Zauber, Ann; Tosteson, Tor Devin; Chubak, Jessica

Ann Appl Stat. 2020 Jun;14(2):1030-1044. Epub 2020-06-29.

PubMed abstract

Association of Azithromycin Use With Cardiovascular Mortality

Authors: Zaroff JG; Cheetham TC; Palmetto N; Almers L; Quesenberry C; Schneider J; Gatto N; Corley DA

JAMA Netw Open. 2020 06 01;3(6):e208199. Epub 2020-06-01.

PubMed abstract

Validation of an Algorithm to Identify Patients at Risk for Colorectal Cancer Based on Laboratory Test and Demographic Data in Diverse, Community-Based Population

Authors: Schneider J; Layefsky E; Udaltsova N; Levin TR; Corley DA

Clin Gastroenterol Hepatol. 2020 Apr 29.

PubMed abstract

COVID-19: What Should Clinicians and Scientists Do and When?

Authors: Corley DA; Peek RM

Gastroenterology. 2020 Mar 19.

PubMed abstract

COVID-19: Long-term Planning for Procedure-based Specialties During Extended Mitigation and Suppression Strategies

Authors: Rouillard S; Liu VX; Corley DA

Gastroenterology. 2020 May 18.

PubMed abstract

A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors

Authors: Calcaterra SL; Burnett-Hartman AN; Powers JD; Corley DA; McMullen CM; Pawloski PA; Feigelson HS

BMC Cancer. 2020 May 03;20(1):373. Epub 2020-05-03.

PubMed abstract

Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population

Authors: Lee JK; Merchant SA; Schneider JL; Jensen CD; Fireman BH; Quesenberry CP; Corley DA

Am J Gastroenterol. 2020 05;115(5):706-715.

PubMed abstract

Election of Anil Rustgi and Raymond DuBois to the National Academy of Medicine

Authors: Corley DE; Peek RM

Gastroenterology. 2020 04;158(5):1196. Epub 2020-03-04.

PubMed abstract

Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer

Authors: Archambault AN; Sakoda LC; Corley DA; Hayes RB; et al.

Gastroenterology. 2020 04;158(5):1274-1286.e12. Epub 2019-12-19.

PubMed abstract

Promises and Potential Pitfalls of Shared Decision-making in Cancer Screening

Authors: Haug U; Senore C; Corley DA

Gastroenterology. 2020 03;158(4):802-805. Epub 2019-12-05.

PubMed abstract

Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population

Authors: Lee JK; Levin TR; Fireman BH; Quesenberry CP; Corley DA; et al.

Gastroenterology. 2020 03;158(4):884-894.e5. Epub 2019-10-04.

PubMed abstract

Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium

Authors: Barlow WE; Corley DA; Silverberg MJ; Tiro JA; et al.

J Natl Cancer Inst. 2020 03 01;112(3):238-246.

PubMed abstract

Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort

Authors: Schneider, Jennifer L; Feigelson, Heather Spencer; Quinn, Virginia P; McMullen, Carmit; Pawloski, Pamela A; Powers, John D; Sterrett, Andrew T; Arterburn, David; Corley, Douglas A

Perm J. 2020;24.

PubMed abstract

Incidence rates of cardiovascular outcomes in a community-based population of cancer patients

Authors: Masson R; Titievsky L; Corley DA; Zhao W; Lopez AR; Schneider J; Zaroff JG

Cancer Med. 2019 12;8(18):7913-7923. Epub 2019-10-30.

PubMed abstract

Effect of Sex, Age and Positivity Threshold on Fecal Immunochemical Test Accuracy: a Systematic Review and Meta-Analysis

Authors: Selby K; Levine EH; Doan C; Gies A; Brenner H; Quesenberry C; Lee JK; Corley DA

Gastroenterology. 2019 12;157(6):1494-1505. Epub 2019-08-22.

PubMed abstract

Diabetes in relation to Barrett’s esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett’s and Esophageal Adenocarcinoma Consortium

Authors: Petrick JL; Corley DA; Cook MB; et al.

Cancer. 2019 12 01;125(23):4210-4223. Epub 2019-09-06.

PubMed abstract

Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations

Authors: Callahan CL; Corley DA; Zhao WK; Hofmann JN; et al.

Cancer Causes Control. 2019 Nov 28.

PubMed abstract

Morbidity and Mortality After Surgery for Nonmalignant Colorectal Polyps: A 10-Year Nationwide Analysis

Authors: Ma C; Teriaky A; Sheh S; Forbes N; Heitman SJ; Jue TL; Munroe CA; Jairath V; Corley DA; Lee JK

Am J Gastroenterol. 2019 11;114(11):1802-1810.

PubMed abstract

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline

Authors: Helsingen LM; Corley DA; Guyatt G; et al.

BMJ. 2019 Oct 02;367:l5515. Epub 2019-10-02.

PubMed abstract

No Association Between Vitamin D Status and Risk of Barrett’s Esophagus or Esophageal Adenocarcinoma-a Mendelian Randomization Study

Authors: Dong J; Corley DA; Thrift AP; et al.

Clin Gastroenterol Hepatol. 2019 10;17(11):2227-2235.e1. Epub 2019-02-01.

PubMed abstract

Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network

Authors: Burnett-Hartman AN; Kushi LH; Corley DA; Lu CY; et al.

JCO Clin Cancer Inform. 2019 09;3:1-10.

PubMed abstract

Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth

Authors: Corley DA

Gastroenterology. 2019 09;157(3):604-607. Epub 2019-07-30.

PubMed abstract

Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium

Authors: Burnett-Hartman AN; Corley DA; Lee JK; Zheng Y; et al.

EGEMS (Wash DC). 2019 Aug 02;7(1):37. Epub 2019-08-02.

PubMed abstract

Validation of the Hepatocellular Carcinoma Early detection Screening (HES) algorithm in a Cohort of Veterans with Cirrhosis

Authors: Tayob N; Christie I; Richardson P; Feng Z; White DL; Davila J; Corley DA; Kanwal F; El-Serag HB

Clin Gastroenterol Hepatol. 2019 08;17(9):1886-1893.e5. Epub 2018-12-14.

PubMed abstract

Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study

Authors: Li D; Levin TR; Corley DA; Bergoffen J; et al.

Ann Intern Med. 2019 07 02;171(1):19-26. Epub 2019-06-11.

PubMed abstract

Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting

Authors: Lam JO; Hurley LB; Udaltsova N; Alexeeff SE; Klein DB; Corley DA; Silverberg MJ

J Acquir Immune Defic Syndr. 2019 07 01;81(3):284-291.

PubMed abstract

Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network

Authors: Burnett-Hartman AN; Powers JD; Chubak J; Corley DA; Ghai NR; McMullen CK; Pawloski PA; Sterrett AT; Feigelson HS

Cancer Causes Control. 2019 Jul;30(7):747-755. Epub 2019-05-17.

PubMed abstract

Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type

Authors: Breen N; Corley DA; PROSPR consortium; et al.

Am J Prev Med. 2019 05;56(5):e143-e152.

PubMed abstract

Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett’s Esophagus?

Authors: Fitzgerald RC; Corley DA

Gastroenterology. 2019 04;156(5):1228-1231. Epub 2019-03-05.

PubMed abstract

Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network

Authors: Doria-Rose VP; Corley DA; Kushi LH; Greene SM; et al.

EGEMS (Wash DC). 2019 Mar 29;7(1):7. Epub 2019-03-29.

PubMed abstract

Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort

Authors: Kamineni A; Silverberg MJ; Corley DA; PROSPR consortium; et al.

Int J Cancer. 2019 03 15;144(6):1460-1473. Epub 2018-12-20.

PubMed abstract

Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study

Authors: Selby K; Jensen CD; Zhao WK; Lee JK; Slam A; Schottinger JE; Bacchetti P; Levin TR; Corley DA

Clin Transl Gastroenterol. 2019 02;10(2):e00010.

PubMed abstract

Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings

Authors: Lee JK; Levin TR; Fireman BH; Quesenberry CP; Corley DA; et al.

JAMA Netw Open. 2019 09 04;2(9):e1911513. Epub 2019-09-04.

PubMed abstract

Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems

Authors: Chubak J; Corley DA; PROSPR consortium; et al.

Cancer Epidemiol Biomarkers Prev. 2019 01;28(1):91-98. Epub 2018-11-20.

PubMed abstract

Modifiable Failures in the Colorectal Cancer Screening Process and Their Association with Risk of Death

Authors: Doubeni CA; Levin TR; Corley DA; et al.

Gastroenterology. 2019 01;156(1):63-74.e6. Epub 2018-09-27.

PubMed abstract

Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening

Authors: Ghai NR; Jensen CD; Corley DA; Doubeni CA; Schottinger JE; Zauber AG; Lee AT; Contreras R; Levin TR; Lee JK; Quinn VP

Clin Transl Gastroenterol. 2018 09 21;9(9):186. Epub 2018-09-21.

PubMed abstract

Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers

Authors: Tollivoro TA; Levin TR; Fireman B; Quesenberry CP; Corley DA; et al.

Gastrointest Endosc. 2019 01;89(1):168-176.e3. Epub 2018-08-23.

PubMed abstract

Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey

Authors: McMullen C; Corley DA; Feigelson HS; et al.

Support Care Cancer. 2019 Jan;27(1):147-156. Epub 2018-06-12.

PubMed abstract

Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing

Authors: Lee JK; Jensen CD; Levin TR; Zauber AG; Doubeni CA; Zhao WK; Corley DA

J Clin Gastroenterol. 2019 01;53(1):e25-e30.

PubMed abstract

Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study

Authors: Selby K; Lee JK; Levin TR; Corley DA; et al.

Ann Intern Med. 2018 10 02;169(7):439-447. Epub 2018-09-18.

PubMed abstract

Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large, Community-based Population

Authors: Levin TR; Corley DA; Lee JK; Quesenberry CP; Fireman BH; Doubeni CA; et al.

Gastroenterology. 2018 11;155(5):1383-1391.e5. Epub 2018-07-19.

PubMed abstract

Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population

Authors: Bakr O; Zhao W; Corley D

J Clin Gastroenterol. 2018 Nov/Dec;52(10):873-879.

PubMed abstract

Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis

Authors: Callahan CL; Hofmann JN; Corley DA; Zhao WK; Shuch B; Chow WH; Purdue MP

Cancer Epidemiol. 2018 10;56:31-37. Epub 2018-07-18.

PubMed abstract

Overdiagnosis in Colorectal Cancer Screening: Time to Acknowledge a Blind Spot

Authors: Kalager M; Wieszczy P; Lansdorp-Vogelaar I; Corley DA; Bretthauer M; Kaminski MF

Gastroenterology. 2018 Sep;155(3):592-595. Epub 2018-08-01.

PubMed abstract

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer

Authors: Rutter MD; Corley DA; Sanduleanu S; et al.

Gastroenterology. 2018 09;155(3):909-925.e3. Epub 2018-06-27.

PubMed abstract

Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett’s Esophagus: An Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium

Authors: Wang Z; Shaheen NJ; Whiteman DC; Anderson LA; Vaughan TL; Corley DA; El-Serag HB; Rubenstein JH; Thrift AP

Am J Gastroenterol. 2018 08;113(8):1148-1155. Epub 2018-06-08.

PubMed abstract

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium

Authors: Doubeni CA; Corley DA; Armstrong K; et al.

CA Cancer J Clin. 2018 05;68(3):199-216. Epub 2018-03-30.

PubMed abstract

Patterns and predictors or repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States

Authors: Singal AG; Corley DA; Halm EA; et al.

Am J Gastroenterol. 2018 05;113(5):746-754. Epub 2018-02-27.

PubMed abstract

Diagnosis of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting

Authors: Li D; Corley DA; Levin TR; et al.

Gastrointest Endosc. 2018 Mar;87(3):755-765.e1. Epub 2017-08-24.

PubMed abstract

Cancer incidence and mortality risks in a large US Barrett’s oesophagus cohort

Authors: Cook MB; Coburn SB; Lam JR; Taylor PR; Schneider JL; Corley DA

Gut. 2018 03;67(3):418-529. Epub 2017-01-04.

PubMed abstract

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study

Authors: Rutter CM; Tosteson ANA; Tosteson ANA; et al.

Cancer Epidemiol Biomarkers Prev. 2018 02;27(2):158-164. Epub 2017-11-17.

PubMed abstract

Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study

Authors: Doubeni CA; Corley DA; Levin TR; Fletcher RH; et al.

Gut. 2018 02;67(2):291-298. Epub 2016-10-12.

PubMed abstract

The 75th Diamond Anniversary of Gastroenterology: 1943-2018

Authors: Peek RM; Corley DA

Gastroenterology. 2018 01;154(1):1-5. Epub 2017-11-09.

PubMed abstract

Determining Risk of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants

Authors: Dong J; Corley DA; Thrift AP; et al.

Gastroenterology. 2017 Dec 13.

PubMed abstract

Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer

Authors: Meester RGS; Doubeni CA; Zauber AG; van Ballegooijen M; Corley DA; Lansdorp-Vogelaar I

Int J Cancer. 2017 12 01;141(11):2359-2367. Epub 2017-08-31.

PubMed abstract

Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study

Authors: Feliciano EMC; Kroenke CH; Kwan ML; Alexeeff S; Corley D; Caan BJ; et al.

JAMA Oncol. 2017 12 01;3(12):e172319.

PubMed abstract

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review

Authors: Selby K; Baumgartner C; Levin TR; Doubeni CA; Zauber AG; Schottinger J; Jensen CD; Lee JK; Corley DA

Ann Intern Med. 2017 Oct 17;167(8):565-575. Epub 2017-10-10.

PubMed abstract

Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system

Authors: Suarez-Sarmiento A; Yao X; Hofmann JN; Syed JS; Zhao WK; Purdue MP; Chow WH; Corley D; Shuch B

Int J Urol. 2017 10;24(10):765-770. Epub 2017-09-15.

PubMed abstract

Primary care visit use after positive fecal immunochemical test for colorectal cancer screening

Authors: Hillyer GC; Jensen CD; Zhao WK; Neugut AI; Lebwohl B; Tiro JA; Kushi LH; Corley DA

Cancer. 2017 Oct 01;123(19):3744-3753. Epub 2017-06-16.

PubMed abstract

Germline variation in inflammation-related pathways and risk of Barrett’s oesophagus and oesophageal adenocarcinoma

Authors: Buas MF; Risch HA; Madeleine MM; et al.

Gut. 2017 Oct;66(10):1739-1747. Epub 2016-08-02.

PubMed abstract

Dietary sugar/starches intake and Barrett’s esophagus: a pooled analysis

Authors: Li N; Petrick JL; Steck SE; Bradshaw PT; McClain KM; Niehoff NM; Engel LS; Shaheen NJ; Corley DA; Vaughan TL; Gammon MD

Eur J Epidemiol. 2017 Sep 01.

PubMed abstract

Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program

Authors: Fedewa SA; Corley DA; Jensen CD; Zhao W; Goodman M; Jemal A; Ward KC; Levin TR; Doubeni CA

Am J Prev Med. 2017 Sep;53(3):335-344. Epub 2017-04-17.

PubMed abstract

The Reply

Authors: Lo Re V; Carbonari DM; Lewis JD; Roy JA; Corley DA

Am J Med. 2017 Aug;130(8):e369.

PubMed abstract

Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test

Authors: Doubeni CA; Corley DA; Levin TR

JAMA. 2017 Aug 01;318(5):483.

PubMed abstract

The Troublesome Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma

Authors: Schneider JL; Corley DA

Gastrointest Endosc Clin N Am. 2017 Jul;27(3):353-364.

PubMed abstract

Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors

Authors: Feigelson HS; McMullen CK; Madrid S; Sterrett AT; Powers JD; Blum-Barnett E; Pawloski PA; Ziegenfuss JY; Quinn VP; Arterburn DE; Corley DA

J Cancer Surviv. 2017 Jun;11(3):393-400. Epub 2017-01-13.

PubMed abstract

Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis

Authors: Corley DA; Lee JK; Quesenberry CP; Fireman BH; Levin TR; et al.

JAMA. 2017 Apr 25;317(16):1631-1641.

PubMed abstract

Oral bisphosphonates and colorectal cancer

Authors: Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC

Sci Rep. 2017 Mar 10;7:44177. Epub 2017-03-10.

PubMed abstract

Endoscopist Fatigue Estimates and Colonoscopic Adenoma Detection in a Large Community-Based Setting

Authors: Lee A; Jensen CD; Marks AR; Zhao WK; Doubeni CA; Zauber AG; Quinn VP; Levin TR; Corley DA

Gastrointest Endosc. 2017 Mar;85(3):601-610.e2. Epub 2016-10-01.

PubMed abstract

Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems

Authors: Balasubramanian BA; Garcia MP; Corley DA; Doubeni CA; Haas JS; Kamineni A; Quinn VP; Wernli K; Zheng Y; Skinner CS

Medicine (Baltimore). 2017 Mar;96(11):e6326.

PubMed abstract

Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue

Authors: Levin TR; Corley DA; Berger BM; et al.

Dig Dis Sci. 2017 Mar;62(3):678-688. Epub 2017-01-02.

PubMed abstract

Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency

Authors: Lam JR; Schneider JL; Quesenberry CP; Corley DA

Gastroenterology. 2017 Mar;152(4):821-829.e1. Epub 2016-11-24.

PubMed abstract

Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system

Authors: Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP

Am J Obstet Gynecol. 2017 Feb;216(2):151.e1-151.e9. Epub 2016-10-14.

PubMed abstract

Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature

Authors: Doubeni CA; Jensen CD; Fedewa SA; Quinn VP; Zauber AG; Schottinger JE; Corley DA; Levin TR

J Am Board Fam Med. 2016 11/12;29(6):672-681.

PubMed abstract

Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status

Authors: Gowda C; Corley DA; Lo Re V; et al.

Open Forum Infect Dis. 2017 Spring;4(2):ofx012. Epub 2017-01-28.

PubMed abstract

Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett’s Esophagus

Authors: Thrift AP; Anderson LA; Murray LJ; Cook MB; Shaheen NJ; Rubenstein JH; El-Serag HB; Vaughan TL; Schneider JL; Whiteman DC; Corley DA

Am J Gastroenterol. 2016 Nov;111(11):1528-1535. Epub 2016-08-30.

PubMed abstract

Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System

Authors: Mehta SJ; Levin TR; Corley DA; Doubeni CA; et al.

J Gen Intern Med. 2016 Nov;31(11):1323-1330. Epub 2016-07-13.

PubMed abstract

Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems

Authors: Burnett-Hartman AN; Corley DA; PROSPR Consortium; et al.

Am J Prev Med. 2016 Oct;51(4):e107-15. Epub 2016-04-01.

PubMed abstract

Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity

Authors: McCarthy AM; Corley DA; PROSPR consortium; et al.

Am J Prev Med. 2016 Oct;51(4):507-12. Epub 2016-04-28.

PubMed abstract

Genome-wide association studies in oesophageal adenocarcinoma and Barrett’s oesophagus: a large-scale meta-analysis

Authors: Gharahkhani P; Corley DA; Schumacher J; et al.

Lancet Oncol. 2016 Oct;17(10):1363-1373. Epub 2016-08-12.

PubMed abstract

Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach

Authors: Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA

J Gen Intern Med. 2016 Oct;31(10):1190-7. Epub 2016-06-08.

PubMed abstract

Inverse Association Between Gluteofemoral Obesity and Risk of Barrett’s Esophagus in a Pooled Analysis

Authors: Kendall BJ; Corley DA; Thrift AP; et al.

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1412-1419.e3. Epub 2016-06-02.

PubMed abstract

Consequences of Increasing Time to Colonoscopy Examination Following Positive Result From Fecal Colorectal Cancer Screening Test

Authors: Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1445-1451.e8. Epub 2016-05-19.

PubMed abstract

Leukocyte telomere length in relation to the risk of Barrett’s esophagus and esophageal adenocarcinoma

Authors: Wennerström EC; Corley DA; Liao LM; et al.

Cancer Med. 2016 Sep;5(9):2657-65. Epub 2016-07-06.

PubMed abstract

Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly

Authors: Klabunde CN; Corley DA; PROSPR consortium; et al.

Am J Prev Med. 2016 Sep;51(3):e67-75. Epub 2016-06-22.

PubMed abstract

Racial disparities in renal cell carcinoma: a single-payer healthcare experience

Authors: Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B

Cancer Med. 2016 Aug;5(8):2101-8. Epub 2016-05-26.

PubMed abstract

The Dawning of a New Editorial Board for Gastroenterology

Authors: Corley DA; Peek RM

Gastroenterology. 2016 07;151(1):4-8. Epub 2016-05-20.

PubMed abstract

Reply

Authors: Lo Re V; Forde KA; Goldberg DS; Lewis JD; Carbonari DM; Reddy KR; Roy J; Sha D; Strom BL; Corley DA

Clin Gastroenterol Hepatol. 2016 06;14(6):918-919. Epub 2016-02-15.

PubMed abstract

Reducing Variation in the “Standard of Care” for Cancer Screening: Recommendations From the PROSPR Consortium

Authors: Corley DA; Haas JS; Kobrin S

JAMA. 2016 May 17;315(19):2067-8.

PubMed abstract

Colorectal Cancer Health Disparities and the Role of US Law and Health Policy

Authors: Doubeni CA; Corley DA; Zauber AG

Gastroenterology. 2016 05;150(5):1052-5. Epub 2016-03-24.

PubMed abstract

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study

Authors: Jensen CD; Corley DA; Lee JK; Quesenberry CP; Levin TR; Mysliwiec PA; et al.

Ann Intern Med. 2016 Apr 5;164(7):456-63. Epub 2016-01-26.

PubMed abstract

Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium

Authors: Tosteson AN; Corley DA; PROSPR consortium; et al.

J Gen Intern Med. 2016 Apr;31(4):372-9.

PubMed abstract

Polymorphisms in genes in the androgen pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma

Authors: Ek WE; Corley DA; Lagergren J; et al.

Int J Cancer. 2016 Mar 1;138(5):1146-52. Epub 2015-10-05.

PubMed abstract

Factors Influencing Variation in Physician Adenoma Detection Rates: a Theory-Based Approach for Performance Improvement

Authors: Atkins L; Hunkeler EM; Jensen CD; Michie S; Lee JK; Doubeni CA; Zauber AG; Levin TR; Quinn VP; Corley DA

Gastrointest Endosc. 2016 Mar;83(3):617-26.e2. Epub 2015-09-11.

PubMed abstract

Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status

Authors: Lo Re V; Corley DA; et al.

Am J Med. 2016 Mar;129(3):283-91.e5. Epub 2015-11-17.

PubMed abstract

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems

Authors: Chubak J; Corley DA; Levin TR; PROSPR consortium; et al.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50.

PubMed abstract

Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett’s Esophagus

Authors: Thomas SJ; Almers L; Schneider J; Graham JE; Havel PJ; Corley DA

Dig Dis Sci. 2016 Jan;61(1):70-9. Epub 2015-09-22.

PubMed abstract

What makes a “good” colonoscopy quality indicator?

Authors: Lee JK; Corley DA

Gastrointest Endosc. 2016 Jan;83(1):179-81.

PubMed abstract

Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors

Authors: Schneider JL; Kolitsopoulos F; Corley DA

Aliment Pharmacol Ther. 2016 Jan;43(1):73-82. Epub 2015-11-06.

PubMed abstract

Adiponectin may modify the risk of Barrett’s esophagus in patients with gastroesophageal reflux disease

Authors: Almers LM; Graham JE; Havel PJ; Corley DA

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2256-64.e1-3. Epub 2015-01-26.

PubMed abstract

Risk of Acute Liver Failure in Patients with Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model

Authors: Lo Re V; Corley DA; et al.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2360-8. Epub 2015-06-27.

PubMed abstract

Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR

Authors: Goodman M; Fletcher RH; Doria-Rose VP; Jensen CD; Zebrowski AM; Becerra TA; Quinn VP; Zauber AG; Corley DA; Doubeni CA

J Comp Eff Res. 2015 Nov;4(6):541-51. Epub 2015-07-23.

PubMed abstract

Quality Indicators for the Management of Barrett’s Esophagus, Dysplasia and Esophageal Adenocarcinoma: International Consensus Recommendations from AGA Symposium

Authors: Sharma P; Corley D; Wang K; et al.

Gastroenterology. 2015 Nov;149(6):1599-606. Epub 2015-08-19.

PubMed abstract

Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk

Authors: Lee E; Corley DA; Wu AH; et al.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1801-3. Epub 2015-09-12.

PubMed abstract

METFORMIN USE AND RISK OF COLORECTAL ADENOMA AFTER POLYPECTOMY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Authors: Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1692-8. Epub 2015-09-16.

PubMed abstract

A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett’s esophagus

Authors: Dai JY; Corley DA; Vaughan TL; et al.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1739-47. Epub 2015-09-16.

PubMed abstract

Does Human Papillomavirus Cause Esophageal Adenocarcinoma?

Authors: Corley D; Silverberg MJ

Clin Gastroenterol Hepatol. 2015 Jul;13(7):1369-70. Epub 2014-12-24.

PubMed abstract

Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018

Authors: Meester RG; Doubeni CA; Zauber AG; Goede SL; Levin TR; Corley DA; Jemal A; Lansdorp-Vogelaar I

Cancer. 2015 Jul 1;121(13):2281-5. Epub 2015-03-12.

PubMed abstract

The authors respond

Authors: Hofmann JN; Corley DA; Colt JS; Shuch B; Chow WH; Purdue MP

Epidemiology. 2015 Jul;26(4):e49.

PubMed abstract

Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model

Authors: Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Jensen CD; van der Meulen MP; Levin TR; Quinn VP; Schottinger JE; Zauber AG; Corley DA; van Ballegooijen M

JAMA. 2015 Jun 16;313(23):2349-58.

PubMed abstract

Population-representative Incidence of Drug-induced Acute Liver Failure Based on an Analysis of an Integrated Healthcare System

Authors: Goldberg DS; Corley DA; Lo Re V; et al.

Gastroenterology. 2015 Jun;148(7):1353-61.e3. Epub 2015-02-28.

PubMed abstract

BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia

Authors: Bennett C; DeCaestecker J; Jankowski J; et al.

Am J Gastroenterol. 2015 May;110(5):662-82; quiz 683. Epub 2015-04-14.

PubMed abstract

Diet and Upper Gastrointestinal Malignancies

Authors: Abnet CC; Corley DA; Freedman ND; Kamangar F

Gastroenterology. 2015 May;148(6):1234-1243.e4. Epub 2015-02-11.

PubMed abstract

Building Data Infrastructure to Evaluate and Improve Quality: PCORnet

Authors: Corley DA; Feigelson HS; Lieu TA; McGlynn EA

J Oncol Pract. 2015 May;11(3):204-6.

PubMed abstract

Adjusting for Patient Demographics Has Minimal Effects on Rates of Adenoma Detection in a Large, Community-based Setting

Authors: Jensen CD; Levin TR; Lee JK; Fireman BH; Quesenberry CP; Corley DA; et al.

Clin Gastroenterol Hepatol. 2015 Apr;13(4):739-46. Epub 2014-10-25.

PubMed abstract

Development and validation of an algorithm for classifying colonoscopy indication

Authors: Lee JK; Jensen CD; Lee A; Doubeni CA; Zauber AG; Levin TR; Zhao WK; Corley DA

Gastrointest Endosc. 2015 Mar;81(3):575-582.e4. Epub 2015-01-08.

PubMed abstract

Colorectal cancer deaths attributable to nonuse of screening in the United States

Authors: Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Goede SL; Levin TR; Quinn VP; Ballegooijen Mv; Corley DA; Zauber AG

Ann Epidemiol. 2015 Mar;25(3):208-213.e1. Epub 2014-12-05.

PubMed abstract

Aspirin and Nonsteroidal Anti-Inflammatory Drug Use and the Risk of Barrett’s Esophagus

Authors: Schneider JL; Zhao WK; Corley DA

Dig Dis Sci. 2015 Feb;60(2):436-43. Epub 2014-09-12.

PubMed abstract

A review of the epidemiology of Barrett’s oesophagus and oesophageal adenocarcinoma

Authors: Schneider JL; Corley DA

Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):29-39. Epub 2014-12-03.

PubMed abstract

Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus

Authors: Palles C; Corley DA; Jankowski J; et al.

Gastroenterology. 2015 Feb;148(2):367-78. Epub 2014-11-05.

PubMed abstract

Imputation of the Rare HOXB13 G84E Mutation and Cancer Risk in a Large Population-Based Cohort

Authors: Hoffmann TJ; Sakoda LC; Habel LA; Asgari MM; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS; et al.

PLoS Genet. 2015 Jan;11(1):e1004930. Epub 2015-01-28.

PubMed abstract

Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett’s Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium

Authors: Lagergren K; Corley DA; Lagergren J; et al.

PLoS ONE. 2015;10(9):e0138738. Epub 2015-09-25.

PubMed abstract

Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers

Authors: Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC

PLoS ONE. 2015;10(10):e0140180. Epub 2015-10-07.

PubMed abstract

Chronic Kidney Disease and Risk of Renal Cell Carcinoma: Differences by Race

Authors: Hofmann JN; Corley DA; Zhao WK; Colt JS; Shuch B; Chow WH; Purdue MP

Epidemiology. 2015 Jan;26(1):59-67.

PubMed abstract

MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium

Authors: Buas MF; Shaheen NJ; Vaughan TL; et al.

PLoS ONE. 2015;10(6):e0128617. Epub 2015-06-03.

PubMed abstract

Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma

Authors: Buas MF; Corley DA; Vaughan TL; et al.

Carcinogenesis. 2014 Dec;35(12):2740-7. Epub 2014-10-03.

PubMed abstract

Importance of determining indication for colonoscopy: implications for practice and policy original

Authors: Singal AG; Gupta S; Lee J; Halm EA; Rutter CM; Corley D; Inadomi J

Clin Gastroenterol Hepatol. 2014 Dec;12(12):1958-63.e1-3.

PubMed abstract

Vertical transmission of hepatitis B virus

Authors: Kubo A; Shlager L; Corley DA

Ann Intern Med. 2014 Nov 18;161(10):763.

PubMed abstract

Obesity and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus: A Mendelian Randomization Study

Authors: Thrift AP; Corley DA; Whiteman DC; et al.

J Natl Cancer Inst. 2014 Nov;106(11). Epub 2014-09-30.

PubMed abstract

Assessing bowel preparation quality using the mean number of adenomas per colonoscopy

Authors: Hillyer GC; Lebwohl B; Rosenberg RM; Neugut AI; Wolf R; Basch CH; Mata J; Hernandez E; Corley DA; Shea S; Basch CE

Therap Adv Gastroenterol. 2014 Nov;7(6):238-46.

PubMed abstract

Alcohol and the Risk of Barrett’s Esophagus: A Pooled Analysis from the International BEACON Consortium

Authors: Thrift AP; Cook MB; Vaughan TL; Anderson LA; Murray LJ; Whiteman DC; Shaheen NJ; Corley DA

Am J Gastroenterol. 2014 Oct;109(10):1586-94. Epub 2014-07-22.

PubMed abstract

Risk of Esophageal Adenocarcinoma Decreases with Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization

Authors: Thrift AP; Corley DA; Vaughan TL; et al.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1667-76.e1. Epub 2014-02-12.

PubMed abstract

Multitarget stool DNA testing for colorectal-cancer screening.

Authors: Lee, Jeffrey K JK; Terdiman, Jonathan P JP; Corley, Douglas A DA

The New England journal of medicine. 2014 07 10;371(2):186. Epub --.

PubMed abstract

The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium

Authors: Tiro JA; Levin TR; Corley DA; Klabunde C; et al.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1147-58. Epub 2014-06-10.

PubMed abstract

Developing a data infrastructure for a learning health system: the PORTAL network

Authors: McGlynn EA; Lieu TA; Go AS; Corley DA; Kahn MG; et al.

J Am Med Inform Assoc. 2014 Jul-Aug;21(4):596-601. Epub 2014-05-12.

PubMed abstract

Prevention of Vertical Transmission of Hepatitis B: An Observational Study

Authors: Kubo A; Shlager L; Marks AR; Lakritz D; Beaumont C; Gabellini K; Corley DA

Ann Intern Med. 2014 Jun 17;160(12):828-35.

PubMed abstract

Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis

Authors: Yuhara H; Corley DA; Nakahara F; Nakajima T; Koike J; Igarashi M; Suauki T; Mine T

J Gastroenterol. 2014 Jun;49(6):992-1000. Epub 2013-11-14.

PubMed abstract

Gastric acid-inhibiting medications and vitamin B12 deficiency–reply

Authors: Corley D; Lam J; Schneider J

JAMA. 2014 Apr 9;311(14):1445-6.

PubMed abstract

Adenoma detection rate and risk of colorectal cancer and death

Authors: Corley DA; Lee JK; Fireman BH; Levin TR; Quesenberry CP; et al.

N Engl J Med. 2014 Apr 3;370(14):1298-306.

PubMed abstract

Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis

Authors: Lee JK; Liles EG; Bent S; Levin TR; Corley DA

Ann Intern Med. 2014 Feb 4;160(3):171.

PubMed abstract

Reply

Authors: Corley DA

Gastroenterology. 2014 Feb;146(2):588-9. Epub 2013-12-19.

PubMed abstract

Gastroesophageal Reflux in Relation to Adenocarcinomas of the Esophagus: A Pooled Analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)

Authors: Cook MB; Corley DA; Vaughan TL; et al.

PLoS ONE. 2014;9(7):e103508. Epub 2014-07-30.

PubMed abstract

Dietary guideline adherence for gastroesophageal reflux disease

Authors: Kubo A; Block G; Quesenberry CP; Buffler P; Corley DA

BMC Gastroenterol. 2014;14:144. Epub 2014-08-14.

PubMed abstract

Approaches for classifying the indications for colonoscopy using detailed clinical data

Authors: Fassil H; Adams KF; Weinmann S; Doria-Rose VP; Johnson E; Williams AE; Corley DA; Doubeni CA

BMC Cancer. 2014;14:95. Epub 2014-02-15.

PubMed abstract

Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency

Authors: Lam JR; Schneider JL; Zhao W; Corley DA

JAMA. 2013 Dec 11;310(22):2435-42.

PubMed abstract

A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett’s esophagus

Authors: Levine DM; Corley DA; Vaughan TL; et al.

Nat Genet. 2013 Dec;45(12):1487-93. Epub 2013-10-13.

PubMed abstract

Sex-specific associations between body mass index, waist circumference and the risk of Barrett’s oesophagus: a pooled analysis from the international BEACON consortium

Authors: Kubo A; Cook MB; Shaheen NJ; Vaughan TL; Whiteman DC; Murray L; Corley DA

Gut. 2013 Dec;62(12):1684-91.

PubMed abstract

Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy

Authors: Eldridge RC; Doubeni CA; Fletcher RH; Zauber AG; Corley DA; Doria-Rose VP; Goodman M

J Med Screen. 2013 Dec;20(4):198-207. Epub 2013-10-21.

PubMed abstract

Germline Genetic Contributions to Risk for Esophageal Adenocarcinoma, Barrett’s Esophagus, and Gastroesophageal Reflux

Authors: Ek WE; Corley DA; BEACON study investigators; et al.

J Natl Cancer Inst. 2013 Nov 20;105(22):1711-8. Epub 2013-10-29.

PubMed abstract

Impact of Endoscopic Surveillance on Mortality from Barrett’s Esophagus-Associated Esophageal Adenocarcinomas

Authors: Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS

Gastroenterology. 2013 Aug;145(2):312-9.e1. Epub 2013 May 11.

PubMed abstract

Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis

Authors: Coleman HG; Murray LJ; Hicks B; Bhat SK; Kubo A; Corley DA; Cardwell CR; Cantwell MM

Nutr Rev. 2013 Jul;71(7):474-82. Epub 2013 Apr 24.

PubMed abstract

Can You Stop Surveillance After Radiofrequency Ablation of Barrett’s Esophagus? A Glass Half Full

Authors: Corley DA

Gastroenterology. 2013 Jul;145(1):39-42.

PubMed abstract

Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease

Authors: Yuhara H; Steinmaus C; Corley D; Koike J; Igarashi M; Suzuki T; Mine T

Aliment Pharmacol Ther. 2013 May;37(10):953-62.

PubMed abstract

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study

Authors: Doubeni CA; Corley DA; Levin TR; Weiss NS; et al.

Ann Intern Med. 2013 Mar 5;158(5 Pt 1):312-20.

PubMed abstract

The Road Ahead: What if Gastroenterologists Were Accountable for Preventing Colorectal Cancer?

Authors: Lee JK; Levin TR; Corley DA

Clin Gastroenterol Hepatol. 2013 Mar;11(3):204-7.

PubMed abstract

Variation of Adenoma Prevalence by Age, Sex, Race, and Colon Location in a Large Population: Implications for Screening and Quality Programs

Authors: Corley DA; Jensen CD; Marks AR; Zhao WK; de Boer J; Levin TR; Doubeni C; Fireman BH; Quesenberry CP

Clin Gastroenterol Hepatol. 2013 Feb;11(2):172-80. Epub 2012 Sep 14.

PubMed abstract

Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium

Authors: Hoyo C; Corley DA; Gammon MD; et al.

Int J Epidemiol. 2012 Dec;41(6):1706-18. Epub 2012 Nov 12.

PubMed abstract

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus

Authors: Su Z; Corley DA; Wellcome Trust Case Control Consortium 2; et al.

Nat Genet. 2012 Oct;44(10):1131-6. Epub 2012 Sep 9.

PubMed abstract

A Combination of Esomeprazole and Aspirin Reduce Tissue Concentrations of Prostaglandin E2 in Patients with Barrett’s Esophagus

Authors: Falk GW; Corley DA; Della'Zanna G; et al.

Gastroenterology. 2012 Oct;143(4):917-26.e1. Epub 2012 Jul 11.

PubMed abstract

Barrett’s Esophagus: Who Should Receive Ablation and How Can We Get the Best Results?

Authors: Corley DA; Bergman JJ

Gastroenterology. 2012 Sep;143(3):524-6. Epub 2012 Jul 25.

PubMed abstract

Diabetes, Hypertension and Hyperlipidemia: Prevalence Over Time and Impact on Long-Term Survival After Liver Transplantation

Authors: Parekh J; Corley DA; Feng S

Am J Transplant. 2012 Aug;12(8):2181-7. Epub 2012 Apr 30.

PubMed abstract

The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett’s Esophagus

Authors: Sharma P; Savides TJ; Canto MI; Corley DA; Falk GW; Goldblum JR; Wang KK; Wallace MB; Wolfsen HC

Gastrointest Endosc. 2012 Aug;76(2):252-4.

PubMed abstract

Consensus Statements for Management of Barrett’s Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

Authors: Bennett C; Corley DA; Jankowski JA; et al.

Gastroenterology. 2012 Aug;143(2):336-46. Epub 2012 Apr 24.

PubMed abstract

The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett’s Esophagus and Esophageal Adenocarcinoma Consortium

Authors: Lubin JH; Corley DA; Whiteman DC; et al.

Cancer Epidemiol. 2012 Jun;36(3):306-16. Epub 2012 Apr 13.

PubMed abstract

Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries?

Authors: Chuang KI; Corley D; Postlethwaite DA; Merchant M; Harris HW

Am J Surg. 2012 Apr;203(4):480-7. Epub 2012 Feb 9.

PubMed abstract

Cigarette Smoking Increases Risk of Barrett’s Esophagus: an Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium

Authors: Cook MB; Shaheen NJ; Anderson LA; Giffen C; Chow WH; Vaughan TL; Whiteman DC; Corley DA

Gastroenterology. 2012 Apr;142(4):744-53. Epub 2012 Jan 11.

PubMed abstract

Non-Steroidal Anti-Inflammatory Drug Use Reduces Risk for Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis

Authors: Liao LM; Corley DA; Wu AH; et al.

Gastroenterology. 2012 Mar;142(3):442-452.e5; quiz e22-3. Epub 2011 Nov 19.

PubMed abstract

The Future of Colon Cancer Screening: What Do We Recommend and Will It Be Too Much, Too Little, or Just Right?

Authors: Corley DA

Gastroenterology. 2011 Dec;141(6):1956-8. Epub 2011 Oct 21.

PubMed abstract

Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer?

Authors: Yuhara H; Steinmaus C; Cohen SE; Corley DA; Tei Y; Buffler PA

Am J Gastroenterol. 2011 Nov;106(11):1911-21; quiz 1922. Epub 2011 Sep 13.

PubMed abstract

Can we improve adenoma detection rates? A systematic review of intervention studies

Authors: Corley DA; Jensen CD; Marks AR

Gastrointest Endosc. 2011 Sep;74(3):656-65. Epub 2011 Jul 13.

PubMed abstract

Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium

Authors: Freedman ND; Corley DA; Whiteman DC; et al.

Gut. 2011 Aug;60(8):1029-37. Epub 2011 Mar 14.

PubMed abstract

Understanding cancer incidence in Barrett’s esophagus: light at the end of the tunnel

Authors: Corley DA

J Natl Cancer Inst. 2011 Jul 6;103(13):994-5. Epub 2011 Jun 16.

PubMed abstract

Dietary factors and the risks of oesophageal adenocarcinoma and Barrett’s oesophagus

Authors: Kubo A; Corley DA; Jensen CD; Kaur R

Nutr Res Rev. 2010 Dec;23(2):230-46. Epub 2010 Jul 13.

PubMed abstract

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium

Authors: Cook MB; Nyren O; Chow WH; et al.

J Natl Cancer Inst. 2010 Sep 8;102(17):1344-53. Epub 2010 Aug 17.

PubMed abstract

Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis

Authors: Cronin-Fenton DP; Murray LJ; Whiteman DC; Cardwell C; Webb PM; Jordan SJ; Corley DA; Sharp L; Lagergren J; Barrett's Esophagus ACBI

Eur J Cancer. 2010 Jul;46(11):2067-76. Epub 2010 Apr 22.

PubMed abstract

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients

Authors: Corley DA; Kubo A; Zhao W; Quesenberry C

Gastroenterology. 2010 Jul;139(1):93-101. Epub 2010 Mar 27.

PubMed abstract

Chemoprevention in Barrett’s esophagus: are we there yet, are we there yet…?

Authors: Corley DA

Clin Gastroenterol Hepatol. 2009 Dec;7(12):1266-8. Epub 2009 Sep 16.

PubMed abstract

Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States

Authors: Wong RJ; Corley DA

Dig Dis Sci. 2009 Sep;54(9):2031-9. Epub 2009 Jan 1.

PubMed abstract

Diagnosing Barrett’s esophagus: reliability of clinical and pathologic diagnoses

Authors: Corley DA; Kubo A; DeBoer J; Rumore GJ

Gastrointest Endosc. 2009 May;69(6):1004-10. Epub 2009 Jan 18.

PubMed abstract

Cigarette smoking and the risk of Barrett’s esophagus

Authors: Kubo A; Levin TR; Block G; Rumore G; Quesenberry CP Jr; Buffler P; Corley DA

Cancer Causes Control. 2009 Apr;20(3):303-11. Epub 2008 Oct 14.

PubMed abstract

Alcohol types and sociodemographic characteristics as risk factors for Barrett’s esophagus

Authors: Kubo A; Levin TR; Block G; Rumore GJ; Quesenberry CP Jr; Buffler P; Corley DA

Gastroenterology. 2009 Mar;136(3):806-15. Epub 2008 Nov 27.

PubMed abstract

Race, ethnicity, sex and temporal differences in Barrett’s oesophagus diagnosis: a large community-based study, 1994-2006

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P

Gut. 2009 Feb;58(2):182-8. Epub 2008 Oct 31.

PubMed abstract

Effects of dietary fiber, fats, and meat intakes on the risk of Barrett’s esophagus

Authors: Kubo A; Block G; Quesenberry CP Jr; Buffler P; Corley DA

Nutr Cancer. 2009;61(5):607-16.

PubMed abstract

Hemochromatosis gene status as a risk factor for Barrett’s esophagus

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore GJ; Quesenberry C; Buffler P

Dig Dis Sci. 2008 Dec;53(12):3095-102. Epub 2008 May 10.

PubMed abstract

Iron intake and body iron stores as risk factors for Barrett’s esophagus: a community-based study

Authors: Corley DA; Kubo A; Levin TR; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Block G

Am J Gastroenterol. 2008 Dec;103(12):2997-3004. Epub 2008 Oct 1.

PubMed abstract

Helicobacter pylori and gastroesophageal reflux disease: a case-control study

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P; Parsonnet J

Helicobacter. 2008 Oct;13(5):352-60.

PubMed abstract

Dietary antioxidants, fruits, and vegetables and the risk of Barrett’s esophagus

Authors: Kubo A; Levin TR; Block G; Rumore GJ; Quesenberry CP Jr; Buffler P; Corley DA

Am J Gastroenterol. 2008 Jul;103(7):1614-23; quiz 1624.

PubMed abstract

Racial and ethnic variations in hepatocellular carcinoma incidence within the United States

Authors: Wong R; Corley DA

Am J Med. 2008 Jun;121(6):525-31.

PubMed abstract

Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Parsonnet J

Gut. 2008 Jun;57(6):727-33. Epub 2007 Sep 25.

PubMed abstract

Dietary patterns and the risk of Barrett’s esophagus

Authors: Kubo A; Levin TR; Block G; Rumore GJ; Quesenberry CP Jr; Buffler P; Corley DA

Am J Epidemiol. 2008 Apr 1;167(7):839-46. Epub 2008 Jan 23.

PubMed abstract

Current surveillance and therapeutic options for barrett esophagus

Authors: Douglas C

Gastroenterol Hepatol (N Y). 2008 Mar;4(3):183-6.

PubMed abstract

Cancer incidence in Barrett’s esophagus: does it really matter, and who’s counting anyway?

Authors: Corley DA

Gastrointest Endosc. 2008 Mar;67(3):399-401.

PubMed abstract

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas

Authors: Corley DA; Kubo A; Zhao W

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):352-8.

PubMed abstract

Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?

Authors: Corley DA

Gut. 2007 Nov;56(11):1493-4.

PubMed abstract

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California

Authors: Mahadevan U; Sandborn WJ; Li DK; Hakimian S; Kane S; Corley DA

Gastroenterology. 2007 Oct;133(4):1106-12. Epub 2007 Jul 25.

PubMed abstract

Abdominal obesity and body mass index as risk factors for Barrett’s esophagus

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA

Gastroenterology. 2007 Jul;133(1):34-41; quiz 311. Epub 2007 Apr 25.

PubMed abstract

Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus

Authors: de Martel C; Haggerty TD; Corley DA; Vogelman JH; Orentreich N; Parsonnet J

Am J Gastroenterol. 2007 Jun;102(6):1166-72. Epub 2007 Mar 22.

PubMed abstract

Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms

Authors: Corley DA; Kubo A; Zhao W

Gut. 2007 Jun;56(6):756-62. Epub 2006 Oct 17.

PubMed abstract

New-onset diabetes and pancreatic cancer

Authors: Gupta S; Vittinghoff E; Bertenthal D; Corley D; Shen H; Walter LC; McQuaid K

Clin Gastroenterol Hepatol. 2006 Nov;4(11):1366-72; quiz 1301. Epub 2006 Sep 1.

PubMed abstract

Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis

Authors: Corley DA; Kubo A

Am J Gastroenterol. 2006 Nov;101(11):2619-28. Epub 2006 Sep 4.

PubMed abstract

Barrett’s esophagus and medications that relax the lower esophageal sphincter

Authors: Corley DA; Levin TR; Habel LA; Buffler PA

Am J Gastroenterol. 2006 May;101(5):937-44.

PubMed abstract

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

Authors: Kubo A; Corley DA

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):872-8.

PubMed abstract

Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma

Authors: de Martel C; Llosa AE; Farr SM; Friedman GD; Vogelman JH; Orentreich N; Corley DA; Parsonnet J

J Infect Dis. 2005 Mar 1;191(5):761-7. Epub 2005 Jan 20.

PubMed abstract

Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas

Authors: Corley DA; Kubo A

J Natl Cancer Inst. 2004 Sep 15;96(18):1383-7.

PubMed abstract

Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States

Authors: Kubo A; Corley DA

Am J Gastroenterol. 2004 Apr;99(4):582-8.

PubMed abstract

Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial

Authors: Corley DA; Katz P; Wo JM; Stefan A; Patti M; Rothstein R; Edmundowicz S; Kline M; Mason R; Wolfe MM

Gastroenterology. 2003 Sep;125(3):668-76.

PubMed abstract

How should we select health professionals for studies?

Authors: Verma R; Corley DA

Outcomes Manag. 2003 Jul-Sep;7(3):129-33.

PubMed abstract

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

Authors: Corley DA; Kerlikowske K; Verma R; Buffler P

Gastroenterology. 2003 Jan;124(1):47-56.

PubMed abstract

Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States

Authors: Kubo A; Corley DA

Cancer. 2002 Nov 15;95(10):2096-102.

PubMed abstract

Surveillance and survival in Barrett’s adenocarcinomas: a population-based study

Authors: Corley DA; Levin TR; Habel LA; Weiss NS; Buffler PA

Gastroenterology. 2002 Mar;122(3):633-40.

PubMed abstract

Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database

Authors: Corley DA; Buffler PA

Int J Epidemiol. 2001 Dec;30(6):1415-25.

PubMed abstract

Back To Top